ABSTRACT Deucravacitinib, an oral, selective tyrosine kinase 2 inhibitor, is approved in multiple countries for the treatment of moderate to severe plaque psoriasis, as well as generalized pustular and erythrodermic psoriasis in Japan. Deucravacitinib 6 mg once daily was efficacious and well tolerated through 3 years in the pooled population of ...
Yukari Okubo +12 more
wiley +1 more source
Relationship Between Floppy Eyelid Syndrome and Obstructive Sleep Apnea Syndrome: An Umbrella Review. [PDF]
Napoli GTO +3 more
europepmc +1 more source
Fatal Cutaneous Mucormycosis Initially Misdiagnosed as Necrotizing Fasciitis in an Uncontrolled Diabetic Patient: A Case Report Highlighting Diagnostic Delay. [PDF]
Hartantri Y +7 more
europepmc +1 more source
How to perform Doppler examination of the maternal ophthalmic artery
Ultrasound in Obstetrics &Gynecology, EarlyView.
A. Youssef, M. Paoli, K. H. Nicolaides
wiley +1 more source
Limited Efficacy of Autologous Mesenchymal Stromal Cell Injections in Immunomodulatory-Dependent Dogs With Aqueous Deficient Dry Eye Disease. [PDF]
Leonard BC +9 more
europepmc +1 more source
Surgical outcome of eyelid retraction correction using novel spacer filamentous knitted polyester fabric in thyroid eye disease. [PDF]
Mandal SK +4 more
europepmc +1 more source
Multimodal treatment of canine lower eyelid mast cell tumours: lip-to-lid reconstruction and sentinel lymph node mapping in two cases. [PDF]
Herman I +3 more
europepmc +1 more source

